Innovation

Simpler Method of Producing Functional Cytochrome B5 and Other Membrane Polypeptides

Wisconsin Alumni Research Foundation (University of Wisconsin)
posted on 06/23/2009

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing an improved method of producing functional membrane polypeptides, such as cytochrome b5.

Suggested Uses

  • In vitro assays that utilize cytochrome b5 or other membrane proteins
  • Studying SCD activity

Advantages

  • Enables synthesis of large quantities of pure, functional and full length cytochrome b5
  • Fusion protein is soluble in aqueous solution.
  • Does not require reconstitution, refolding or reassociation with the co-factor heme
  • Fusion protein is highly stable and can be recognized by cytochrome b5 reductase
  • MBP moiety or other solubilizing agent easily can be released when needed.
  • Allows cytochrome b5 to be stored as a soluble fusion protein without the need for contaminating detergents
  • Fusion protein may include an affinity purification tag.
  • Can be used to produce other functional membrane polypeptides, including full length cytochrome b5 reductase, peptidoglycan glycosyltransferases, prostaglandin H2 synthase-1, monoamine oxidase B, cyclooxygenase-2 and carnitine palmitoyl transferase

Innovation Details
 

Detailed Description

Cytochrome b5 is an electron transport protein found in bacteria, protozoans, yeasts and mammals. This membrane protein is required for the activity of stearoyl-CoA desaturase (SCD), an integral membrane desaturase that plays a role in obesity, diabetes, hypertension, cardiovascular disease, immune disorders, degenerative neurological diseases and skin diseases.

Cytochrome b5 is a useful tool for researchers studying SCD activity. However, current methods of making large quantities of functional cytochrome b5 to use in assays are labor intensive and time consuming. Improved techniques for synthesizing full length cytochrome b5 are needed.

UW-Madison researchers have developed a simpler method of producing and purifying functional membrane polypeptides, such as cytochrome b5. This method utilizes a recombinant expression vector that expresses a fusion of cytochrome b5 and a solubilizing agent, such as maltose binding protein (MBP).

The vector can be used to express the fusion protein in solution. The protein optionally can be purified, and then a simple chemical or enzymatic cleavage reaction can release the MBP moiety when the functional, full length cytochrome b5 is needed.

In addition, the inventors discovered that the carboxy terminus of the cytochrome b5 peptide functions as a membrane anchor. To use this method to synthesize other functional membrane proteins that do not have a C-terminal membrane anchor, this anchor section can be fused to the protein, allowing it to spontaneously attach to a membrane when the solubilizing agent is released.

File Number: P07407US 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Emily Bauer at Wisconsin Alumni Research Foundation (University of Wisconsin) for more information.

request more info
People

Case Manager:

Icon_avatar Emily Bauer

Innovations (130)

Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

4,076 members 12,312 innovations 109 organizations

Browse

Alfred R Berkeley - Chairman - Pipeline Financial Group, Inc.

"Our economy is inextricably intertwined with university innovations. Unfortunately, our country’s short-term outlook often interferes with the long-term possibilities of university research and collaborations with industry and entrepreneurs..."  read more...